Provided by Tiger Trade Technology Pte. Ltd.

ABVC BioPharma, Inc.

1.22
-0.0700-5.43%
Post-market: 1.220.00000.00%18:57 EDT
Volume:77.64K
Turnover:96.07K
Market Cap:31.02M
PE:-3.10
High:1.37
Open:1.32
Low:1.19
Close:1.29
52wk High:5.48
52wk Low:0.6491
Shares:25.42M
Float Shares:20.60M
Volume Ratio:1.75
T/O Rate:0.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3933
EPS(LYR):-0.3933
ROE:-119.49%
ROA:-31.25%
PB:2.79
PE(LYR):-3.10

Loading ...

Luo Yonghao Discloses ADHD Diagnosis: May Cease Large-Scale Events if Medication Change Fails or Physical Condition Issues Persist

Deep News
·
Dec 31, 2025

How sport and athletes can show the realities of neurodiversity

cityam
·
Dec 21, 2025

Grant Cardone Says ADHD Isn't A Disorder But 'Misunderstood Genius' — It's A 'Gift From God' That Helps People Chase Multiple Passions

Benzinga
·
Dec 11, 2025

China Resources Double-Crane Pharmaceutical's ADHD Capsules Included in China's Insurance Catalog

MT Newswires Live
·
Dec 09, 2025

Tonix Pharma’s IND Clearance Boosts MDD Treatment Efforts

TIPRANKS
·
Nov 25, 2025

When ADHD Meds Are Just the Start -- WSJ

Dow Jones
·
Nov 22, 2025

For Kids, ADHD Pills Are Often Just the Start -- WSJ

Dow Jones
·
Nov 21, 2025

Millions of Kids Are on ADHD Pills. For Many, It's the Start of a Drug Cascade. -- WSJ

Dow Jones
·
Nov 20, 2025

Jury Convicts Done Global Founder In Adderall Distribution Scheme: WSJ Report

Benzinga
·
Nov 20, 2025

ADHD Startup's Founder Is Found Guilty of Conspiracy in Adderall Case -- WSJ

Dow Jones
·
Nov 19, 2025

Cingulate Inc.’s Promising Market Position Bolstered by Strategic Partnerships and Innovative ADHD Treatment

TIPRANKS
·
Nov 16, 2025

Press Release: Cybin Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights

Dow Jones
·
Nov 13, 2025

BrainsWay Receives FDA Clearance of Deep TMS™ as Adjunct Therapy for Major Depressive Disorder (MDD) in Adolescents Aged 15 to 21

GlobeNewswire
·
Nov 13, 2025

TRICARE West Expands NeuroStar® TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression

GlobeNewswire
·
Nov 12, 2025

Press Release: Cingulate Names Industry Veteran Bryan Downey Chief Commercial Officer to Lead Launch Preparation for CTx-1301

Dow Jones
·
Nov 10, 2025

Mind Medicine price target raised to $25 from $16 at Canaccord

TIPRANKS
·
Nov 07, 2025

Press Release: MindMed Reports Q3 2025 Financial Results and Business Updates

Dow Jones
·
Nov 07, 2025

Yukiguni Maitake Sees FY Net Y2.01B

Dow Jones
·
Nov 06, 2025

ABVC BioPharma Q3 EPS $(0.05) Down From $(0.03) YoY, Sales $795.950K Up From $389.276K YoY

Benzinga
·
Nov 03, 2025

ABVC BioPharma Acquires Taiwan Land for $11 Million

Reuters
·
Nov 03, 2025